GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to taking Ozempic: It may help manage chronic kidney disease (CKD). On January 28,

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a long wait for human organ transplants.

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig kidney into a living person. The hospital, which completed the world's first xenotransplantation in March 2024, said the latest transplant was completed during a 2.5-hour procedure on Jan. 25.

The U.S. Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in cross-species transplantation.

The US Food and Drug Administration approved clinical trials that will transplant organs from genetically modified pigs into patients with kidney failure.